Consortium Outlines 3 Solutions to Maximize the Benefit and Affordability of Targeted Cancer Drugs

Cancer - United States
doi 10.1002/cncr.31673
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Wiley

Related search

The Cancer Cell Proteome and Transcriptome Predicts Sensitivity to Targeted and Cytotoxic Drugs

Life Science Alliance
Plant ScienceEcologyGeneticsMolecular BiologyBiochemistryMutagenesisHealthToxicology
2019English

Resistance to Targeted Cancer Drugs Through Hepatocyte Growth Factor Signaling

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2014English

Heterogeneity and Plasticity of Human Breast Cancer Cells in Response to Molecularly-Targeted Drugs

Frontiers in Oncology
Cancer ResearchOncology
2019English

EGFR-targeted Cancer Therapy: Promise, Problems and Potential Solutions

Translational Medicine
2011English

Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project

Applied Health Economics and Health Policy
MedicineHealth PolicyEconomicsEconometrics
2019English

Homeowners as Engaged Participants: Determining Information Needs to Maximize the Environmental Benefit of Green Renovations

2016English

Companion Diagnostics for Targeted Cancer Drugs €“ Clinical and Regulatory Aspects

Frontiers in Oncology
Cancer ResearchOncology
2014English

Cost-Aware Fronthaul Rate Allocation to Maximize Benefit of Multi-User Reception in C-Ran

2017English

Novel Mechanisms of Resistance to Investigational Molecularly Targeted Drugs

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy